Chondrogenesis of Human Adipose Tissue Derived Mesenchymal Stem Cells (ATMSCs) Seeded in Gelatin-Chondroitin-Glucosamine Scaffold

Gelatin-Chondroitin-Glucosamine Scaffold에 접종한 인간지방조직-유래 중간엽 줄기세포의 연골형성

  • Received : 2011.04.07
  • Accepted : 2011.06.11
  • Published : 2011.06.30

Abstract

The present experiment was performed to evaluate the chondrogenic differentiation potential of human adipose tissue-derived mesenchymal stem cells (ATMSCs) in the chondrogenic induction medium (CIM) with transforming growth factor-${\beta}1$ (TGF-${\beta}1$) and to evaluate the chondrogenic differentiation of ATMSCs seeded in gelatin-chondroitinglucosamine scaffold (GCG-scaffold). ATMSCs and mouse chondrocytes were cultured in the basic medium and CIM without TGF-${\beta}1$ (CIM1) or with TGF-${\beta}1$ (CIM2) for chondrogenic differentiation potential. The chondrogenic differentiation of ATMSCs was evaluated by glycosaminoglycan (GAG) synthesis and histochemical staining. In pellet culture, GAG synthesis of ATMSCs and chondrocyte was increased in culture on 14 days, but higher in CIM1 than basic medium, especially highest in CIM2. Cartilage matrix was observed in ATMSCs cultured in CIM2 on 14 days by Safranin O and trichrome staining. In well plate culture, proliferation of ATMSCs was continuously increased in culture on 10 days and higher in CIM than basic medium. The cell adhesion rate of ATMSCs seeded in flask or scaffolds was continuously increased during culture period, but higher in scaffold than flask. GAG synthesis of ATMSCs seeded in scaffolds showed no change in control group. In the CIM groups, GAG synthesis of ATMSCs was continuously increased than control group during culture period, especially very high in CIM2 and in the GCG-scaffold was slightly higher than the gelatin scaffold (G-scaffold). The present results demonstrated that ATMSCs showed an low chondrogenic differentiation potential, compared to mouse chondrocytes for 14 days of culture. TGF-${\beta}1$ is important factor in chondrogenic differentiation of ATMSCs. Gelatin scaffold was considered to increasing the effective chondrogenic differentiation environment. ATMSCs seeded in GCG-scaffold was more effective in chondrogenesis than in G-scaffold. Conclusively, the present results demonstrated that the treatment of chondroitin and glucosamine in the scaffold was more effective to promote the cartilage matrix formation.

본 실험은 transforming growth factor-${\beta}1$(TGF-${\beta}1$)이 첨가된 chondrogenic induction medium(CIM)을 이용하여 인간지방조직에서 유래된 중간엽 줄기세포(human adipose tissue-derived mesenchymal stem cells, ATMSCs)의 연골형성능과 gelatin-chondroitin-glucosamine scaffold(GCG-scaffold)에 접종시킨 ATMSCs의 연골형성능을 알아보고자 수행하였다. ATMSCs와 생쥐 chondrocyte를 기본배양액과 TGF-${\beta}1$이 첨가되지 않은 CIM1 및 TGF-${\beta}1$이 첨가된 CIM2에서 배양하여 연골형성능을 비교하였다. ATMSCs의 연골형성은 gelatin scaffold(G-scaffold)와 GCG-scaffold를 사용하여 glycosaminoglycan(GAG) 합성과 조직화학적 염색으로 연골기질형성 여부를 확인하였다. 펠렛 배양에서 ATMSCs와 chondrocyte의 GAG합성은 대조군에서 14일의 배양기간 동안 약간 증가하였으나, CIM1과 CIM2배양군은 배양 14일에 대조군에 비해크게 증가하였으며, CIM2 배양군에서 가장 높았다. 그러나 연골기질은 배양 14일에 CIM2 배양군에서만 Safranin O와trichrome에 의해 염색되었다. Well plate에서 배양된 ATMSCs의 증식은 모든 배양군에서 배양 10일까지 계속적인 세포증식이 일어났으며, 대조군에 비해 CIM 배양군이 높았다. ATMSCs 접종 후 플라스크나 scaffold의 세포부착률은 배양시간이 길어짐에 따라 모든 배양군에서 증가하였고, 플라스크에 비해 scaffold에서 더욱 높게 나타났다. Scaffold에 ATMSCs 접종후 GAG 합성은 28일의 배양기간 동안 대조군에서는 별 변화가 없었으나, CIM1, CIM2 배양군은 대조군보다 GAG합성이 증가되었다. CIM2 배양군에서 GAG 합성이 매우 높게 나타났다. 또한 G-scaffold보다 GCG-scaffold에서 GAG 합성이 약간 높게 나타났다. 조직화학적으로 관찰한 ATMSCs의 연골기질형성도 CIM2 배양군의 GCG-scaffold에서 가장높게 나타났다. 본 실험의 결과들을 종합해 볼 때, 펠렛 배양에서 ATMSCs는 생쥐 chondrocyte보다 낮은 연골형성능을 보였고, CIM2 배양군에서만 연골기질이 형성된 것으로 보아 TGF-${\beta}1$이 연골분화에 중요한 요소로 작용한 것이라 사료된다. G-scaffold는 효과적인 연골분화 환경을 제공해 줌으로써 ATMSCs의 세포부착률과 GAG 합성을 증가시키는 것으로보여지며, G-scaffold보다 GCG-scaffold에서 많은 연골기질이 형성된 것은 GCG-scaffold에 첨가된 chondroitin과 glucosamine이연골기질 형성을 촉진시키는 물질로 작용한 것으로 사료된다.

Keywords

References

  1. Awad HA, Halvorsen YC, Gimble JM, Guilak F (2003) Effects of transforming growth factor $\beta$1 and dexamethasone on the growth and chondrogenic differentiation of adipose-derived stromal cells. Tissue Eng 9:1301-1312. https://doi.org/10.1089/10763270360728215
  2. Barry F, Boynton RE, Liu B, Murphy JM (2001) Chondrogenic differentiation of mesenchymal stem cells from bone marrow: Differentiation-dependent gene expression of matrix components. Exp Cell Res 268:189-200. https://doi.org/10.1006/excr.2001.5278
  3. Boo JS, Yamada Y, Okazaki Y, Hibino Y, Okada K, Hata K, Yoshikawa T, Sugiura Y, Ueda M (2002) Tissueengineered bone using mesenchymal stem cells and a biodegradable scaffold. J Craniofac Surg 13:231-239. https://doi.org/10.1097/00001665-200203000-00009
  4. Bosnakovski D, Mizuno M, Kim G, Takagi S, Okumura M, Fujinaga T (2005) Islation and multilineage differentiation of bovine bone marrow mesenchymal stem cells. Cell Tissue Res 319:243-253. https://doi.org/10.1007/s00441-004-1012-5
  5. Buckwalter JA, Mankin HJ (1998) Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect 47:487-504.
  6. Chan D, Lamande SR, Cole WG, Bateman JF (1990) Regulation of procollagen synthesis and processing during ascorbate-induced extracellular matrix accumulation in vitro. Biochem J 269:175-181. https://doi.org/10.1042/bj2690175
  7. Chan PS, Caron JP, Rosa GJ, Orth MW (2005) Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E2 in articular cartilage explant. Osteoarthr Cartil 13:387-394. https://doi.org/10.1016/j.joca.2005.01.003
  8. Dresser R (2001) Ethical issue in embryonic stem cell research. JAMA 285:1439-1440. https://doi.org/10.1001/jama.285.11.1439
  9. Fan H, Hu Y, Zhang C, Li X, Lv R, Ling Q, Zhu R (2006) Cartilage regeneration using mesenchymal stem cells and a PLGA-gelatin/chondroitin/hyaluronate hybrid scaffold. Biomaterials 27:4573-4580. https://doi.org/10.1016/j.biomaterials.2006.04.013
  10. Fukumoto T, Sperling JW, Sanyal A, Fitzsimmons JS, Reinhilz GG, Conevert CA, O'Driscoll SW (2003) Combined effects of insulin-like growth factor-1 and transforming growth factor-$\beta$1 on periosteal mesenchymal cells during chondrogenesis in vitro. Osteoarthr Cartil 11:55-64. https://doi.org/10.1053/joca.2002.0869
  11. Gelse K, Muhle C, Knaup K, Swoboda B, Wiesener M, Henning F, Olk A, Schneider H (2008) Chondrogenic differentiation of growth factor-stimulated precursor cells in cartilage repair tissue is associated with increased HIF-1$\alpha$ activity. Osteoarthr Cartil 16:1457-1465. https://doi.org/10.1016/j.joca.2008.04.006
  12. Goldberg RL, Kolibas LM (1990) An improved method for determining proteoglycans synthesized by chondrocytes in culture. Connective Tissue Research 24(3-4):265-275. https://doi.org/10.3109/03008209009152154
  13. Huang W, Carlsen B, Wulur I, Rudkin G, Ishida K, Wu B (2004) BMP-2 exerts differential effects on differentiation of rabbit bone marrow stromal cells grown in two-dimensional and three-dimensional systems and required for in vitro bone formation in a PLGA scaffold. Exp Cell Res 229:325-334.
  14. Hwang NS, Varghese S, Theprungsirikul P, Canver A, Elisseeff J (2006) Enhanced chondrogenic differentiation of murin embryonic stem cells in hydrogels with glucosamine. Biomaterials 27:6015-6023. https://doi.org/10.1016/j.biomaterials.2006.06.033
  15. Im GI (2005) Chondrogenesis from mesenchymal stem cells derived from adipose tissue on the fibrin scaffold. Current Applied Physics 5:438-443. https://doi.org/10.1016/j.cap.2005.01.006
  16. Indrawattana N, Chen G, Tadokoro M, Shann LH, Ohgushi H, Tateishi T, Tanaka J, Bunyaratvej A (2004) Growth factor combination for chondrogenic induction from human mesenchymal stem cell. Biocem Biophys Res Commum 320:914-919. https://doi.org/10.1016/j.bbrc.2004.06.029
  17. Jackson DW, Simon TM (1999) Tissue engineering principles in orthopaedic surgery. Clin Orthop 367:S31-45. https://doi.org/10.1097/00003086-199910001-00005
  18. Johnstone B, Hering TM, Caplan AL, Goldberg VM, Yoo JU (1998) In vitro chondrogenesis of bone marrowderived mesenchymal progenitor cells. Exp Cell Res 238:265-272. https://doi.org/10.1006/excr.1997.3858
  19. Largo R, Alcarez-Soria MA, Siez-Ortego I, Calvo E, Sanchez- Pernatue O, Egidoo J (2003) Glucosamine inhibits IL-1 beta-induced NF kB activation in human osteoarthritic chondrocytes. Osteoarthr Cartil 11:290-298. https://doi.org/10.1016/S1063-4584(03)00028-1
  20. Lee JW, Kim YH, Kim SH, Han SH, Hahn SB (2004) Chondrogenic differentiation of mesenchymal stem cells and its clinical applications. Yonsei Med J 45:41-47. https://doi.org/10.3349/ymj.2004.45.Suppl.41
  21. Li WJ, Tuli R, Okafor C, Derfoul A, Danielson KG, Hall DJ, Tuan RS (2005) A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 26:599-609. https://doi.org/10.1016/j.biomaterials.2004.03.005
  22. Lien SM, Li WT, Huang TJ (2008) Genipin-crosslinked gelatin scaffolds for articular cartilage tissue engineering with a novel crosslinking method. Mater Sci Eng 28:36-43. https://doi.org/10.1016/j.msec.2006.12.015
  23. Marshall S, Nadeau O, Yamasaki K (2004) Dynamic actions of glucose and glucosamine on hexosamine biosynthesis in isolated adipocytes: differential effects on glucosmine 6-phosphate, UDP-N-acetylglucosamine, and ATP levels. J Biol Chem 279:35313-35319. https://doi.org/10.1074/jbc.M404133200
  24. Mastrogiacomo M, Cancedda R, Quarto R (2001) Effect of different growth factors on the chondrogenic potential of human bone marrow stromal cells. Osteoarthr Cartil 9:S36-S40.
  25. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63. https://doi.org/10.1016/0022-1759(83)90303-4
  26. Nishimura K, Solchaga LA, Caplan AI, Yoo JU, Goldberg VM, Johnstone B (1999) Chondroprogenitor cells of synovial tissue. Arthritis Rheum 42:2631-2637. https://doi.org/10.1002/1529-0131(199912)42:12<2631::AID-ANR18>3.0.CO;2-H
  27. Noth U, Tuli R, Osyczka AM, Danielson KG, Tuan RS (2002) In vitro engineered cartilage constructs produced by press-coating biodegradable polymer with human mesenchymal stem cells. Tissue Eng 8:131-144. https://doi.org/10.1089/107632702753503126
  28. Phornphutkul C, Wu KY, Gruppuso PA (2006) The role of insulin in chondrogenesis. Mol Cellular Endocrinol 249:107-115. https://doi.org/10.1016/j.mce.2006.02.002
  29. Phornphutkul C, Wu KY, Yang X, Chen Q, Gruppuso PA (2004) Insulin-like growth factor-I signaling is modified during chondrocyte differentiation. J Endocrinol 183:477-486. https://doi.org/10.1677/joe.1.05873
  30. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Mooeman DR (1999) Multilineage potential of adult human mesenchymal stem cells. Sci 284:143-147. https://doi.org/10.1126/science.284.5411.143
  31. Ponticiello MS, Schinagl RM, Kadiyala S, Barry FP (2000) Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy. J Biomed Mater Res 52:246-255. https://doi.org/10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
  32. Radice M, Brun P, Cortivo R, Scapinelli R, Battaliard C, Abatangelo G (2000) Hyaluronan-based biopolymers as delivery vehicles for bone-marrow-derived mesenchymal progenitors. J Biomed Mater Res 50:101-109. https://doi.org/10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
  33. Roark EF, Greer K (1994) Transforming growth factor-$\beta$1 and bone morphogenetic protein-2 act by distinct mechanism to promote chick limb cartilage differentiation in vitro. Dev Dyn 200:103-116. https://doi.org/10.1002/aja.1002000203
  34. Rodriguez AM, Elabd C, Amri EZ, Ailhaud G, Dani C (2004) The human adipose tissue is a source of multipotent stem cells. Biocheme 87:125-128.
  35. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T (2005) Comparison of human stem cells derived from various mesenchymal tissues: Superiority of synovium as a cell source. Arthritis Pheum 52:2521-2529. https://doi.org/10.1002/art.21212
  36. Sechriest VF, Miao YJ, Niyibizi C, Westerhausen-Larson A, Matthew HW, Evans CH (2000) GAG-augmented polysaccharide hydrogel: a novel biocompatible and biodegradable material to support chondrogenesis. J Biomed Mater Res 49:534-541. https://doi.org/10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
  37. Sterm BM, Hedrick MH (2005) The growing importance of fat in regenerative medicine. Biotechnol 23:64-66.
  38. Simon C, Peter G (1995) Effects of transforming growth factor beta on proteoglycan synthesis by cell and explant cultures derived from the knee joint meniscus. Ostearthr Res Society 3:127-138. https://doi.org/10.1016/S1063-4584(05)80045-7
  39. Stott NS, Jiang TX, Chuong CM (1999) Successive formation stages of precartilaginous mesenchymal condensation in vitro: modulation of cell adhesion by Wnt-7A and BMP-2. J Cell Phisiol 180:314-324. https://doi.org/10.1002/(SICI)1097-4652(199909)180:3<314::AID-JCP2>3.0.CO;2-Y
  40. Tew SR, Kwan AP, Hann A, Thomson BM, Archer CW (2000) The reactions of articular cartilage to experimental wounding: role of apoptosis. Arthritis Rheum 43:215-225. https://doi.org/10.1002/1529-0131(200001)43:1<215::AID-ANR26>3.0.CO;2-X
  41. Vogel KG, Hernandez DJ (1992) The effects of transforming growth factor beta and serum on proteoglycan synthesis by tendon fibrocartilage. Eur J Cell 59:304-313.
  42. Winter A, Breit S, Parsch D, Benz K, Steck E, Hauner H, Weber RM, Ewerbeck V, Richter W (2003) Cartilagelike gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis Pheum 48:418-429. https://doi.org/10.1002/art.10767
  43. Yoo JU, Barthel TS, Nishimura K, Solchaga L, Caplan AI, Goldberg VM, Johnstone B (1998) The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 80:1745-1757. https://doi.org/10.2106/00004623-199812000-00004
  44. Young BR, Pitt WG, Cooper SL (1988) Protein absorption on polymeric biomaterials. I: Absorption isotherms. J Colloid Interface Sci 124:28-44. https://doi.org/10.1016/0021-9797(88)90321-9
  45. Zuk PA, Zhu M, Ashjian P (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-4295. https://doi.org/10.1091/mbc.E02-02-0105